Importantly, within tumor infiltrating lymphocytes (TILs), the IL-18 receptor complex (IL-18RC) has been reported as preferentially expressed on PD-1+ TpEX (25, 26) meaning that delivery of IL-18 to these cells may induce their preservation/expansion, increase their cytotoxicity and inhibit their terminal exhaustion. Here, IL18 is linked to neoplasm.